Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) were down 2.3% on Friday . The company traded as low as $1.64 and last traded at $1.69. Approximately 25,346 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 62,169,492 shares. The stock had previously closed at $1.73.
BioRestorative Therapies Price Performance
The firm has a market capitalization of $2.80 billion, a P/E ratio of -1.60 and a beta of 102.36. The firm has a 50-day moving average price of $1.73 and a two-hundred day moving average price of $1.73.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- 3 Fintech Stocks With Good 2021 Prospects
- O’Reilly Automotive: An Anytime Buy for Buy-and-Hold Investors
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Chipotle Mexican Grill Serves Smoking Hot Entry Point in Q2
- When to Sell a Stock for Profit or Loss
- Markets Think Robinhood Earnings Could Send the Stock Up
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
